Archives

by in
Entry Author Date Location
Fate CEO Exits for New Co 02/22/11 San Diego
Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off 02/17/11 Boston
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Fluidigm Raises $75M in Second Chance at IPO 02/10/11 San Francisco
Geron CEO Steps Down 02/09/11 San Francisco
Axonia Seeks to Regenerate Nerves a New Way, Sidestepping Stem Cell Controversy 01/25/11 Detroit
Follica Co-Founder and Team Find New Clues About Male Baldness 01/04/11 Boston
John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as “Parallel Entrepreneur” 01/03/11 San Diego
Fluidigm, Maker of Genomic Tools, Takes Second Crack at IPO, Hoping for Less Drama 12/14/10 San Francisco
Aastrom Announces $22.5M Public Offering to Help Fund Stem Cell Trials 12/10/10 Detroit
How to Raise Money for an Honest-to-God Innovative Biotech Startup: Highlights from Convergence 12/06/10 National
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy 10/22/10 Detroit
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology 10/14/10 San Diego
Onyx Delays FDA Push, Vega Aims High Against Diabetes, Stanford Biologist Goes Open Source, & More Bay Area Life Sciences News 10/08/10 San Francisco
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News 10/07/10 Seattle
ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells 10/04/10 Boston
Embryonic Stem Cell Research Foe, Tracy Deisher, Seeks to Market Pro-Life Vaccines 10/01/10 Seattle
Will the Stem Cell Ruling Affect Venture Capital Investing? 09/01/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
AlloCure, With Stem Cell Therapy for Kidney Failure, Arrives in New England with New CEO 07/06/10 Boston
Biotech Investors Should Quit the Marketing Games, and Build Real Innovative Companies 06/30/10 San Francisco
Top 10 Things Michael Bishop Did as UCSF Chancellor 06/22/10 San Francisco
iPierian, With Harvard Science and Kleiner Perkins Cash, Pursues Stem Cells to Make Drugs 06/17/10 San Francisco
Aastrom Biosciences Seeks to Catch Cell Therapy Wave, Ride Dendreon’s Coattails 06/02/10 Detroit
Cyntellect Finds $9M More 05/21/10 San Diego
Stemgent Finds $5.6M More 05/17/10 Boston
Cytori Heartened by Cell Therapy in Two Small Studies of Cardiac Patients 05/07/10 San Diego
Novocell Renamed ViaCyte; Gets 3 Patents 05/06/10 San Diego
Page 2 of 5 « previous page · next page »
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.